Liquid Biopsies: Promises and Pitfalls
Lynette M. Sholl, MD
Christina Lockwood, PhD
This webinar is a recorded presentation of a live broadcast and includes the presentation, handout, and the audience QA.
This session will focus on the principles of cell free DNA biology and approaches to detecting genomic alterations in circulating tumor DNA relevant to the diagnosis and management of solid tumor patients. Areas of controversy, as well as technical developments that may expand the use of liquid biopsy in clinical medicine, will be addressed.
- Recognize the biological and technical challenges that limit the sensitivity of liquid biopsy
- Identify factors that may lead to discrepant results when comparing tumor genomic alterations across platforms or biopsy types
Recording Date: October 9, 2018
Duration: 1 hr
Level of Instruction: Basic
CE Credit for this course has expired.
This webinar is part 4 of a five-part series aimed at breaking down barriers to NSCLC testing and treatment.
For more information on this series, please go here.
Supported by an educational grant from AstraZeneca
Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.